Background and purpose: Good practice guidelines highlight the importance of making people with epilepsy aware of the risk of premature mortality in epilepsy particularly due to sudden unexpected death in epilepsy (SUDEP). The SUDEP and Seizure Safety Checklist ('Checklist') is a structured risk communication tool used in UK clinics. It is not known if sharing structured information on risk factors allows individuals to reduce SUDEP and premature mortality risks. The aim of this study was to ascertain if the introduction of the Checklist in epilepsy clinics led to individual risk reduction. Methods: The Checklist was administered to 130 consecutive people with epilepsy attending a specialized epilepsy neurology clinic and 129 attending an epilepsy intellectual disability (ID) clinic within a 4-month period. At baseline, no attendees at the neurology clinic had received formal risk advice, whereas all those attending the ID clinic had received formal risk advice on multiple occasions for 6 years. The Checklist was readministered 1 year later to each group and scores were compared with baseline and between groups. Results: Of 12 risk factors considered, there was an overall reduction in mean risk score for the general (P = 0.0049) but not for the ID (P = 0.322) population. Subanalysis of the 25% of people at most risk in both populations showed that both sets had a significant reduction in risk scores (P < 0.001). Conclusion: Structured discussion results in behavioural change that reduces individual risk factors. This impact seems to be higher in those who are at current higher risk. It is important that clinicians share risk information with individuals as a matter of public health and health promotion.
Introduction
People will generally modify behaviour and change lifestyle if they feel that there is an advantage or benefit. They need to have a comprehensive understanding of specific risks. Health risks are conveyed by clinicians in a myriad of ways of variable quality and effectiveness. A host of clinical and individual factors play a role in person-centred communication [1] . The lack of a clear structure to capture this quality of communication could influence outcomes.
New guidance from the American Academy of Neurology recognizes the importance of communicating the risk of sudden unexpected death in epilepsy (SUDEP) to people with epilepsy [2] , mirroring the UK's National Institute of Clinical Excellence [3] epilepsy guidance. Both guidelines lack elaboration on how to deliver person-centred risk assessment. Another concern is that epilepsy risk discussion is Correspondence: R. Shankar, Chy Govenek, Threemilestone Industrial Estate, Highertown, Truro, Cornwall TR4 9LD, UK (tel.:+44 1872221553; fax:+44 1872 240765; e-mail: rohit.shankar@nhs.net).
expected to occur shortly after diagnosis. It has, however, been shown in chronic conditions such as epilepsy that risk can change over time and is influenced by varying life factors [4] . People with epilepsy are rarely aware of changing risk, often to their detriment. Thus, what can start as 'low' risk can over time switch to a 'higher' risk without the individual, carers or clinician being fully aware of this [5] . It is therefore important to update risk assessment and feedback based on the course of an individual's epilepsy and how it may change.
There are about half a million people with epilepsy in the UK and, in 2013, almost 1200 of them died as a result of epilepsy, roughly the same number as died from asthma in the same year [6] . This is despite the number of people with asthma being 10 times greater [6] . Over one-third of epilepsy deaths could have been avoidable, whereas only a quarter of asthma deaths were identified as preventable [6] . This suggests that there is significant room for improvement in the way that risk identification and management of people with epilepsy is delivered. It has been shown that the risk of premature mortality in epilepsy is rarely communicated due to lack of clarity of what needs to be said [7] . A recent survey suggests that many specialists do not discuss SUDEP and that risk discussion is arbitrarily led by clinician judgement [8] .
A safety checklist was developed that uses available evidence to determine 19 SUDEP risk factors divided into modifiable and non-modifiable risks [9] . These are on seizures, physical health and psychological and social issues, thus providing individuals with a holistic overview of their current situation [9] . These factors were subsequently examined in those who had died from SUDEP (n = 48) in the UK county of Cornwall (population 550 000) between 2004 and 2012 compared with people with epilepsy who had not died [4] . It was found that 17 factors were associated with SUDEP and directly relevant for people living with epilepsy [10] . These 17 factors form the background of the SUDEP and Seizure Safety Checklist ('Checklist') (https:// www.sudep.org/checklist), a 10-min risk communication tool, and the self-monitoring of epilepsy risk mobile app EpSMon [11] . The Checklist considers risk factors associated with epilepsy mortality, including but not restricted to SUDEP. The Checklist description is provided in Appendix S1 and key risk factors and their narrative are listed in Table 1 .
Of the 19 factors in the original Checklist, 12 were considered modifiable [4, 5, 10] and seven non-modifiable, thus focusing clinicians' discussions with individuals on modifiable factors. The Checklist can be repeated annually, when risk factors change at followup or when there is a treatment change.
We aimed to determine whether the introduction of a risk communication checklist in an epilepsy clinic leads to a reduction in individual SUDEP and epilepsy mortality risk factors.
Methods
We used the Checklist prospectively in two specialist secondary care epilepsy clinics in Cornwall as part of routine clinical practice and audited the findings after two applications 1 year apart. The first clinic was an epilepsy neurology clinic. None of those referred to the neurology clinic had received previous counselling concerning SUDEP risk. The population in this clinic included people with newly diagnosed epilepsy, with epilepsy re-referred from primary care and with treatment-resistant epilepsy on routine follow-up.
The second clinic specialized in epilepsy and intellectual disability (ID) in which discussion of SUDEP risk had been the practice since 2010. All attendees have moderate to profound ID and are thus in 24-h supported care with a designated carer or family member. The administration of the Checklist in this group was directly to a family member or carer. Where eligible, i.e. when the individual was capable of processing risk, feedback was also given by an 'easy-read' format to the individual. This population was considered to be an appropriate comparison group due to previous exposure to discussion of SUDEP risk, being in a 24/7 supported-care environment and having a nominated carer to deliver actions. One would expect that the majority of the modifiable risk factors in this population are better controlled due to the level of supervision and monitoring that people with ID receive in comparison to the general population. All those attending this clinic were recognized as having treatment-resistant epilepsy on routine 3-monthly follow-ups.
Those with epilepsy attending these clinics between November 2015 and March 2016 were counselled on their personal SUDEP and epilepsy risk using the Checklist. The Checklist was administered by an epilepsy nurse or a specialist who had training in this. No baseline comparison between these two populations was performed at the start of the project.
All subjects underwent the application of the Checklist 1 year later to ascertain if the advice provided using the Checklist had reduced risk scores. Those discharged from both clinics in the interim period of 1 year were excluded. The focus was on the 12 modifiable risks.
Seizure change was obtained from case notes by using changes in seizure frequency by counting seizures reported and recorded at clinic appointments in the interim between the applications. 'Change' was defined as at least a 25% change in frequency that was constant for at least 6 months until the reapplication of the Checklist.
The demographic characteristics and risk factors were summarized at baseline in both populations using percentage frequencies for categorical variables and means and SDs for continuous variables. These summary measures were compared across groups to identify baseline differences between the two groups. McNemar's test was used where there were changes in individual risk factors from baseline to follow-up in each clinic group. The threshold for statistical significance was set at P < 0.05.
A risk index was created whereby individuals received a score of 1 for each modifiable risk factor and 0 if they did not have the risk factor. The total score was obtained by a simple sum of the values from 12 risk factors. The distribution of risk scores was plotted separately at baseline and follow-up for each group using boxplots. Differences in the risk scores between baseline and follow-up were assessed using paired t-tests.
To determine if the administration of the Checklist had also made a difference in those identified as being most at risk, the baseline risk scores were ranked separately in each group and a threshold score was chosen such that approximately the top 25% scored above the threshold were subanalysed and compared. This was performed by selecting individuals with a baseline risk score of 5 or more in each group. It is currently unclear how relevant a risk factor this is as it has not been clearly defined Night surveillance (M) Nocturnal seizures were shown to have a fourfold increased risk and accounted for 60% of all SUDEPs in a large control study. Thus, nocturnal surveillance, where present, is considered to be a protective factor Sleeping in prone position (M) This is an independent risk factor demonstrated by several studies including a systematic review The prone position is defined as lying on the belly, chest or face, with or without obstruction of the nose or mouth. Sleeping in the prone position or remaining in a prone position post-seizure is considered a risk Convulsive seizures (M) Combined data from the previous four case-control studies found that this is the most important risk factor Increasing seizure frequency (M) Active seizures that, in the last 6 months, were noted to have an increase in frequency of >25% Assessment for epilepsy surgery (M) This, where available, or referral to tertiary centres, if eligible, can have a positive impact on seizures and SUDEP Duration (>15 years) This has been suggested by several studies, but not after multiple logistical regression analysis for seizure frequency Early-onset epilepsy Where the onset of epilepsy is before the age of 15 years M, modifiable factors.
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Changes in risk scores between baseline and follow-up were compared within these high-risk subgroups as above.
As this exercise did not involve treatment changes, interventions or randomization and as the Checklist is routinely used in clinical practice it was registered as a service evaluation.
Results
The Checklist was applied to 130 consecutive individuals in the neurology clinic and similarly to 129 people in the ID clinic. Demographic and clinical details are provided in Table 2 . During the following year, a total of 39 and 36 of the original cohorts were lost to follow-up or discharged from their respective services and were thus not available for the second check. Therefore, 91 individuals were available from the neurology clinic and 93 from the ID clinic for the second application. The epilepsy duration at baseline had a broad distribution in the general population with 41% having seizures for less than 5 years and 32% having seizures for over 15 years, whereas over 90% of the ID population had seizures for over 15 years. A total of 28% of the general population had generalized seizures as compared with 68% of the ID population. Group differences at baseline were significant for age (P = 0.01), number of antiepileptic drugs (P < 0.001), seizure duration (P < 0.001) and type, i.e. generalized epilepsy (yes/no; P < 0.001), and alcohol abuse (P = 0.002). All other group variables (Table 1) were not significant (P ≥ 0.05).
Changes to the 12 risk factors considered individually are shown in Tables 3 and 4 . Figure 1 shows the distribution of risk scores at baseline and follow-up separately for the general and ID populations. There was an overall reduction in mean risk score for the general (P = 0.049, paired t-test) but not for the ID (P = 0.322) population. Group differences in terms of overall reduction in mean risk score were not significant (P = 0.38). Risk scores were ranked by selecting the top 25% of each group (Table 5) . In both cases, there was a statistically significant mean reduction in risk score (P < 0.001). End analysis of the subgroups of those with a risk score of 5 and above at baseline showed that there was a significant difference between groups, with the general population experiencing a greater reduction in risk scores (P = 0.03).
Discussion
Using the Checklist stimulated open discussions about SUDEP risk. The exercise has acted as a catalyst to improve care and outcomes in the longer term. The value of education and empowerment is intuitive in all areas of clinical risk reduction and is particularly relevant in epilepsy. This is a before and after assessment of the introduction of the Checklist in the general neurology clinic. There may be confounders contributing to the change in risk status, as, for instance, changes in treatment could have reduced risk independently. Ideally, the Checklist should have been validated using a randomized control approach in which controls receive no information on SUDEP, which is currently the practice in many sites. This could, however, be deemed non-ethical as withholding safety information could have implications. Using the ID clinic as a AED, antiepileptic drug. P-value is shown where significant. All other group differences at baseline for variables were non-significant (P ≥ 0.05). Data are given as n (%) except where shown otherwise.
comparison group, however, provides some strengths to the findings as the Checklist had long been used in this setting and modifiable factors were considered to be addressed in this population. Unlike other parts of the UK, Cornwall decommissioned long-stay institutions and hospitals for people with ID over 10 years ago. Most people with ID now live in bespoke placements in the community and are supported on an asrequired basis for their specific needs. The Checklist is used regularly in this population to communicate and mitigate risks. Thus, this population had been previously exposed to the 'intervention', whereas the general population had not. This is not an ideal comparator especially as this group has more treatment resistance and multimorbidity. The two groups could be seen as separate but affiliated cohorts with some shared commonality, such as seizures. Issues such as harmful use of alcohol, 24/7 supervision, assured compliance and reliable seizure feedback from care providers may be confounders.
The focus is on examining if the Checklist could lead to change in modifiable risk factors by structured communication. Thus, irrespective of the nature of the groups, the study ascertains if the Checklist positively influenced a change in modifiable risk especially in the general population group when compared with the ID group. The focus is on changes within each group over a 1-year period.
Looking at the change from baseline with regard to specific factors, the general population group showed significant reduction in the factors of seizure frequency (P = 0.019) and severity (P < 0.001). This suggests that safety advice has possible direct implications on seizure factors. As seizure frequency is the single most important factor associated with SUDEP, change would improve safety. The other factor that showed significant change was sleeping posture (P = 0.046). Although advice was given on this risk and people appear to have made an effort to consciously change their sleeping posture, little can yet be said of its utility.
No change in modifiable factors had been expected In the ID population. This was largely true other than for a positive and significant association with the treatment of depression (P = 0.046). This did not correspond to a direct change in seizure factors or overall risk.
Even the ID population, which at baseline was thought to be 'non-modifiable' from a risk perspective, had a noticeable improvement in the top 25% scores. This highlights that modifiable factors, such as seizure frequency, often fluctuate over time, thus requiring ongoing vigilance.
There were differences between groups in terms of seizures and number of antiepileptic drugs, which may also introduce bias. About one-third of both cohorts were lost for the second assessment and it is unclear if the Checklist had an impact on them. This is one of the first attempts to measure the impact of the introduction of a safety Checklist in SUDEP and seizure risk management. It is important to evaluate the effectiveness of health promotion measures such as this in other clinical settings. Our project also challenges views that attitudes to SUDEP cannot be altered by counselling. A small study in young adults showed a cynical view from the young people [12] and it could be argued that a lack of structured engagement, especially identifying clear areas of change, might have been a possible reason for such an attitude.
Implications for clinical practice
This study supports the introduction of a safety Checklist as it provides some evidence that people with epilepsy and their carers respond to the Checklist in such a way as to reduce seizure risk. Creating such baseline scores and risk stratification for known risk factors is a first step in improving awareness among individuals with epilepsy and also clinicians in such settings. Having ongoing risk discussions, using tools such as the Checklist, to reduce these risks where possible must follow to help tackle premature mortality. Further, as this enables a clinician-patient partnership, it helps to overcome possible hurdles for clinicians and reduces ambiguity that could have resulted due to the lack of communication of risk to date [7, 8] .
Implications for policy
Promoting health promotional checklists in epilepsy may reduce morbidity and mortality as risk factors can be modifiable and change over time, which has important public health implications. 
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